Journal
FEBS LETTERS
Volume 595, Issue 1, Pages 110-122Publisher
WILEY
DOI: 10.1002/1873-3468.13968
Keywords
enzyme mutation; neurodevelopment; O‐ GlcNAcylation; pathogenesis; protein structure
Funding
- UK National Synchrotron
Ask authors/readers for more resources
The mutation UAP1 (A229T) decreases the stability and activity of the UAP1 isoform AGX1, and may be a contributory factor to the patient’s phenotype.
O-GlcNAcylation is a post-translational modification catalysed by O-GlcNAc transferase (OGT). Missense mutations in OGT have been associated with developmental disorders, OGT-linked congenital disorder of glycosylation (OGT-CDG), which are characterized by intellectual disability. OGT relies on the hexosamine biosynthetic pathway (HBP) for provision of its UDP-GlcNAc donor. We considered whether mutations in UDP-N-acetylhexosamine pyrophosphorylase (UAP1), which catalyses the final step in the HBP, would phenocopy OGT-CDG mutations. A de novo mutation in UAP1 (NM_001324114:c.G685A:p.A229T) was reported in a patient with intellectual disability. We show that this mutation is pathogenic and decreases the stability and activity of the UAP1 isoform AGX1 in vitro. X-ray crystallography reveals a structural shift proximal to the mutation, leading to a conformational change of the N-terminal domain. These data suggest that the UAP1(A229T) missense mutation could be a contributory factor to the patient phenotype.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available